K
Kymera Therapeutics, Inc. (KYMR)
NGM – Real vaqt narxi. Valyuta: USD
114.09
+4.47 (4.08%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
114.30
+0.27 (0.24%)
Bozordan keyin: Aug 12, 2026, 5:05 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
114.09
+4.47 (4.08%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
114.30
+0.27 (0.24%)
Bozordan keyin: Aug 12, 2026, 5:05 PM EDT
This stock has a consensus price target of $106.69 based on the ratings of 33 analysts. The high is $155.00 and the low is $44.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 44 | $ 106.69 | $ 155 |
| O’zgarish | -60.19% | -3.46% | 40.25% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-07-30 | 5.24% | Deutsche Bank | $120 | Initiates Coverage On | Hold |
| 2026-07-28 | 18.39% | Guggenheim | $125 → $135 | Maintains | Buy |
| 2026-07-16 | 22.77% | Mizuho | $120 → $140 | Maintains | Outperform |
| 2026-07-13 | 0.85% | RBC Capital | $106 → $115 | Downgrades | Outperform → Sector Perform |
| 2026-06-30 | 9.62% | B of A Securities | $110 → $125 | Maintains | Buy |